Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 21, 2023 at 09:16 pm
Share
Kaya Holdings, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.055116 million compared to USD 0.195186 million a year ago. Net loss was USD 0.732768 million compared to net income of USD 3.1 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.21 a year ago. Diluted loss per share from continuing operations was USD 0.03.
For the six months, sales was USD 0.103361 million compared to USD 0.38385 million a year ago. Net loss was USD 0.665609 million compared to net income of USD 2.03 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.14 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to diluted earnings per share from continuing operations of USD 0.14 a year ago.
Kaya Holdings, Inc. is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Companyâs Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.